Related references
Note: Only part of the references are listed.Lymphocyte-C-reactive protein ratio as a prognostic marker associated with the tumor immune microenvironment in intrahepatic cholangiocarcinoma
Kyohei Yugawa et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2021)
Inflammation-Related Biomarkers for the Prediction of Prognosis in Colorectal Cancer Patients
Takehito Yamamoto et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Prognostic Value of the Preoperative Lymphocyte-C-Reactive Protein Ratio in Hepatocellular Carcinoma Patients Treated with Curative Intent: A Large-Scale Multicentre Study
Yong-Fa Zhang et al.
JOURNAL OF INFLAMMATION RESEARCH (2021)
Lymphocyte-to-C-reactive protein ratio and score are clinically feasible nutrition-inflammation markers of outcome in patients with gastric cancer
Yoshinaga Okugawa et al.
CLINICAL NUTRITION (2020)
Comprehensive Comparative Analysis of Prognostic Value of Systemic Inflammatory Biomarkers for Patients with Stage II/III Colon Cancer
Shinsuke Suzuki et al.
ANNALS OF SURGICAL ONCOLOGY (2020)
Comparison of the prognostic value of inflammation-based scores in early recurrent hepatocellular carcinoma after hepatectomy
Chenwei Wang et al.
LIVER INTERNATIONAL (2020)
Prognostic Nutritional Index, Tumor-infiltrating Lymphocytes, and Prognosis in Patients with Esophageal Cancer
Kazuo Okadome et al.
ANNALS OF SURGERY (2020)
Nutritional assessment and prognosis of oral cancer patients: a large-scale prospective study
Xiaodan Bao et al.
BMC CANCER (2020)
Handgrip weakness, low fat-free mass, and overall survival in non-small cell lung cancer treated with curative-intent radiotherapy
Chris Burtin et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2020)
Neutrophil to lymphocyte ratio and cancer prognosis: an umbrella review of systematic reviews and meta-analyses of observational studies
Meghan A. Cupp et al.
BMC MEDICINE (2020)
Association between obesity and biomarkers of inflammation and metabolism with cancer mortality in a prospective cohort study
Daniel T. Dibaba et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2019)
Predictors and trajectory of performance status in patients with advanced cancer: A secondary data analysis of the international European Palliative Care Cancer Symptom study
Jason W. Boland et al.
PALLIATIVE MEDICINE (2019)
Controlling Nutritional Status (CONUT) score is a prognostic marker for gastric cancer patients after curative resection
Daisuke Kuroda et al.
GASTRIC CANCER (2018)
Pretreatment albumin to globulin ratio can serve as a prognostic marker in human cancers: a meta-analysis
Guo-yue Lv et al.
CLINICA CHIMICA ACTA (2018)
New national data show alarming increase in obesity and noncommunicable chronic diseases in China
Y. Wang et al.
EUROPEAN JOURNAL OF CLINICAL NUTRITION (2017)
Prediagnostic circulating inflammation markers and endometrial cancer risk in the prostate, lung, colorectal and ovarian cancer (PLCO) screening trial
Britton Trabert et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
The role of the systemic inflammatory response in predicting outcomes in patients with operable cancer: Systematic review and meta-analysis
Ross D. Dolan et al.
SCIENTIFIC REPORTS (2017)
Prognostic factors for progression-free and overall survival in advanced biliary tract cancer
J. Bridgewater et al.
ANNALS OF ONCOLOGY (2016)
Nonparametric estimation of time-dependent ROC curves conditional on a continuous covariate
Maria Xose Rodriguez-Alvarez et al.
STATISTICS IN MEDICINE (2016)
Obesity and cancer: inflammation bridges the two
Ryan Kolb et al.
CURRENT OPINION IN PHARMACOLOGY (2016)
Obesity and Cancer Mechanisms: Tumor Microenvironment and Inflammation
Neil M. Iyengar et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
C-reactive protein can upregulate VEGF expression to promote ADSC-induced angiogenesis by activating HIF-1α via CD64/PI3k/Akt and MAPK/ERK signaling pathways
JiaYuan Chen et al.
STEM CELL RESEARCH & THERAPY (2016)
Cancer-related inflammation and treatment effectiveness
Connie I. Diakos et al.
LANCET ONCOLOGY (2014)
Prognostic Value of PLR in Various Cancers: A Meta-Analysis
Xin Zhou et al.
PLOS ONE (2014)
Advance lung cancer inflammation index (ALI) at diagnosis is a prognostic marker in patients with metastatic non-small cell lung cancer (NSCLC): a retrospective review
Syed H. Jafri et al.
BMC CANCER (2013)
The systemic inflammation-based Glasgow Prognostic Score: A decade of experience in patients with cancer
Donald C. McMillan
CANCER TREATMENT REVIEWS (2013)
Interconversion of three measures of performance status: An empirical analysis
Clement Ma et al.
EUROPEAN JOURNAL OF CANCER (2010)
Pooled Safety and Efficacy Analysis Examining the Effect of Performance Status on Outcomes in Nine First-Line Treatment Trials Using Individual Data From Patients With Metastatic Colorectal Cancer
Daniel J. Sargent et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Quantitative evaluation of oxidative stress, chronic inflammatory indices and leptin in cancer patients: Correlation with stage and performance status
G Mantovani et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Alternative methods of interpreting quality of life data in advanced gastrointestinal cancer patients
K Nordin et al.
BRITISH JOURNAL OF CANCER (2001)
Share Paper
